AU2025205244A1 — Polymorphic forms of RAD1901-2HCL

USPTO Abstract

#$%^&*AU2025205244A120250731.pdf##### ABSTRACT Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCl for cancer treatment are also disclosed. ABSTRACT Various polymorphic forms of RAD1901-2HC1, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCI for cancer treatment are also disclosed. 20 25 20 52 44 09 J ul 2 02 5 A B S T R A C T 2 0 2 5 2 0 5 2 4 4 0 9 J u l 2 0 2 5 V a r i o u s p o l y m o r p h i c f o r m s o f R A D 1 9 0 1 - 2 H C 1 , i n c l u d i n g t h r e e c r y s t a l l i n e a n d a m o r p h o u s f o r m s , a r e p r e p a r e d a n d c h a r a c t e r i z e d . U s e s o f t h e v a r i o u s p o l y m o r p h i c f o r m s o f R A D 1 9 0 1 - 2 H C I f o r c a n c e r t r e a t m e n t a r e a l s o d i s c l o s e d .